<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>fosfomycin tromethamine</title><link>http://www.unboundmedicine.com/medline/ebm/research/fosfomycin_tromethamine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925632/full_citation/Acute_generalized_exanthematous_pustulosis__AGEP__induced_by_cefotaxime_</link><description>Chaabane A, Aouam K, Gassab L, et al. <br/><span class="title">Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime. [JOURNAL ARTICLE]</span><br/><span class="source" title="Fundamental &amp; clinical pharmacology">Fundam Clin Pharmacol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925632/abstract/Acute_generalized_exanthematous_pustulosis__AGEP__induced_by_cefotaxime_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925632/full_citation/Acute_generalized_exanthematous_pustulosis__AGEP__induced_by_cefotaxime_">Full Citation</a></description></item><item><title>Cisplatin overdose: toxicities and management.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916578/full_citation/Cisplatin_overdose:_toxicities_and_management_</link><description>Tsang RY, Al-Fayea T, Au HJ <br/><span class="title">Cisplatin overdose: toxicities and management. [Journal Article]</span><br/><span class="source" title="Drug safety : an international journal of medical toxicology and drug experience">Drug Saf 2009; 32(12):1109-22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916578/abstract/Cisplatin_overdose:_toxicities_and_management_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916578/full_citation/Cisplatin_overdose:_toxicities_and_management_">Full Citation</a></description></item><item><title>Fosfomycin: an old, new friend?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915879/full_citation/Fosfomycin:_an_old_new_friend</link><description>Popovic M, Steinort D, Pillai S, et al. <br/><span class="title">Fosfomycin: an old, new friend? [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology">Eur J Clin Microbiol Infect Dis 2009 Nov 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915879/abstract/Fosfomycin:_an_old_new_friend">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915879/full_citation/Fosfomycin:_an_old_new_friend">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915879/Fosfomycin:_an_old_new_friend">Find Related Articles</a> </description></item><item><title>Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906513/full_citation/Acute_uncomplicated_cystitis:_from_surveillance_data_to_a_rationale_for_empirical_treatment_</link><description>Katsarolis I, Poulakou G, Athanasia S, et al. <br/><span class="title">Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment. [JOURNAL ARTICLE]</span><br/><span class="source" title="International journal of antimicrobial agents">Int J Antimicrob Agents 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906513/abstract/Acute_uncomplicated_cystitis:_from_surveillance_data_to_a_rationale_for_empirical_treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906513/full_citation/Acute_uncomplicated_cystitis:_from_surveillance_data_to_a_rationale_for_empirical_treatment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906513/Acute_uncomplicated_cystitis:_from_surveillance_data_to_a_rationale_for_empirical_treatment_">Find Related Articles</a> </description></item><item><title>In Vitro Activity of Fosfomycin Against blaKPC-containing Klebsiella pneumoniae Isolates including those nonsusceptible to tigecycline and/or colistin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19901089/full_citation/In_Vitro_Activity_of_Fosfomycin_Against_blaKPC_containing_Klebsiella_pneumoniae_Isolates_including_those_nonsusceptible_to_tigecycline_and/or_colistin_</link><description>Endimiani A, Patel G, Hujer KM, et al. <br/><span class="title">In Vitro Activity of Fosfomycin Against blaKPC-containing Klebsiella pneumoniae Isolates including those nonsusceptible to tigecycline and/or colistin. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antimicrobial agents and chemotherapy">Antimicrob Agents Chemother 2009 Nov 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19901089/abstract/In_Vitro_Activity_of_Fosfomycin_Against_blaKPC_containing_Klebsiella_pneumoniae_Isolates_including_those_nonsusceptible_to_tigecycline_and/or_colistin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19901089/full_citation/In_Vitro_Activity_of_Fosfomycin_Against_blaKPC_containing_Klebsiella_pneumoniae_Isolates_including_those_nonsusceptible_to_tigecycline_and/or_colistin_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19901089/In_Vitro_Activity_of_Fosfomycin_Against_blaKPC_containing_Klebsiella_pneumoniae_Isolates_including_those_nonsusceptible_to_tigecycline_and/or_colistin_">Find Related Articles</a> </description></item><item><title>[Improvement in the clinical management of urinary infections in a health centre by means of a quality management cycle. Analysis using lot quality assurance sampling.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19896881/full_citation/[Improvement_in_the_clinical_management_of_urinary_infections_in_a_health_centre_by_means_of_a_quality_management_cycle__Analysis_using_lot_quality_assurance_sampling_]</link><description>Tormo Molina J, Santos García MJ, Hortal Carmona J, et al. <br/><span class="title">[Improvement in the clinical management of urinary infections in a health centre by means of a quality management cycle. Analysis using lot quality assurance sampling.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial">Rev Calid Asist 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19896881/abstract/[Improvement_in_the_clinical_management_of_urinary_infections_in_a_health_centre_by_means_of_a_quality_management_cycle__Analysis_using_lot_quality_assurance_sampling_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19896881/full_citation/[Improvement_in_the_clinical_management_of_urinary_infections_in_a_health_centre_by_means_of_a_quality_management_cycle__Analysis_using_lot_quality_assurance_sampling_]">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S1134-282X(09)00050-5">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19896881/[Improvement_in_the_clinical_management_of_urinary_infections_in_a_health_centre_by_means_of_a_quality_management_cycle__Analysis_using_lot_quality_assurance_sampling_]">Find Related Articles</a> </description></item><item><title>Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19856063/full_citation/Characterization_of_beta_lactam_antibiotic_induced_vancomycin_resistant_MRSA__BIVR__in_a_patient_with_septicemia_during_long_term_vancomycin_administration_</link><description>Yamaguchi Y, Hanaki H, Yanagisawa C, et al. <br/><span class="title">Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration. [Journal Article]</span><br/><span class="source" title="Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy">J Infect Chemother 2009 Oct; 15(5):274-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19856063/abstract/Characterization_of_beta_lactam_antibiotic_induced_vancomycin_resistant_MRSA__BIVR__in_a_patient_with_septicemia_during_long_term_vancomycin_administration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19856063/full_citation/Characterization_of_beta_lactam_antibiotic_induced_vancomycin_resistant_MRSA__BIVR__in_a_patient_with_septicemia_during_long_term_vancomycin_administration_">Full Citation</a></description></item><item><title>Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19852849/full_citation/Empiric_antibiotic_therapy_in_acute_uncomplicated_urinary_tract_infections_and_fluoroquinolone_resistance:_a_prospective_observational_study_</link><description>Aypak C, Altunsoy A, Duzgun N <br/><span class="title">Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of clinical microbiology and antimicrobials">Ann Clin Microbiol Antimicrob 2009 Oct 24; 8(1):27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19852849/abstract/Empiric_antibiotic_therapy_in_acute_uncomplicated_urinary_tract_infections_and_fluoroquinolone_resistance:_a_prospective_observational_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19852849/full_citation/Empiric_antibiotic_therapy_in_acute_uncomplicated_urinary_tract_infections_and_fluoroquinolone_resistance:_a_prospective_observational_study_">Full Citation</a></description></item><item><title>[Serovars of Salmonella enterica subspecies enterica and its antimicrobial resistance in slaughterhouse pigs]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19831314/full_citation/[Serovars_of_Salmonella_enterica_subspecies_enterica_and_its_antimicrobial_resistance_in_slaughterhouse_pigs]</link><description>Ibar MP, Vigo G, Piñeyro P, et al. <br/><span class="title">[Serovars of Salmonella enterica subspecies enterica and its antimicrobial resistance in slaughterhouse pigs] [English Abstract, Journal Article]</span><br/><span class="source" title="Revista Argentina de microbiología">Rev Argent Microbiol 2009 Jun-Sep; 41(3):156-62.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19831314/abstract/[Serovars_of_Salmonella_enterica_subspecies_enterica_and_its_antimicrobial_resistance_in_slaughterhouse_pigs]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19831314/full_citation/[Serovars_of_Salmonella_enterica_subspecies_enterica_and_its_antimicrobial_resistance_in_slaughterhouse_pigs]">Full Citation</a></description></item><item><title>Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19828298/full_citation/Clinical_significance_of_the_pharmacokinetic_and_pharmacodynamic_characteristics_of_fosfomycin_for_the_treatment_of_patients_with_systemic_infections_</link><description>Roussos N, Karageorgopoulos DE, Samonis G, et al. <br/><span class="title">Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. [JOURNAL ARTICLE]</span><br/><span class="source" title="International journal of antimicrobial agents">Int J Antimicrob Agents 2009 Oct 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19828298/abstract/Clinical_significance_of_the_pharmacokinetic_and_pharmacodynamic_characteristics_of_fosfomycin_for_the_treatment_of_patients_with_systemic_infections_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19828298/full_citation/Clinical_significance_of_the_pharmacokinetic_and_pharmacodynamic_characteristics_of_fosfomycin_for_the_treatment_of_patients_with_systemic_infections_">Full Citation</a></description></item></channel></rss>